- Home
- FNGR vs COEP Comparison
FNGR vs COEP Comparison
Compare FNGR & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FNGR | COEP |
|---|---|---|
| Founded | 2016 | 2017 |
| Country | Singapore | United States |
| Employees | N/A | 7 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.8M | 72.7M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | FNGR | COEP |
|---|---|---|
| Price | $1.03 | $10.61 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 158.0K | 36.4K |
| Earning Date | 01-15-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $35,607,614.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.05 | $6.32 |
| 52 Week High | $5.20 | $21.41 |
Technical Indicators
Market Signals| Indicator | FNGR | COEP |
|---|---|---|
| Relative Strength Index (RSI) | 37.78 | 38.02 |
| Support Level | N/A | $8.95 |
| Resistance Level | $1.55 | $13.23 |
| Average True Range (ATR) | 0.11 | 0.97 |
| MACD | -0.03 | -0.10 |
| Stochastic Oscillator | 1.80 | 24.38 |
Price Performance
Historical ComparisonAbout FNGR FingerMotion Inc.
FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company business line includes Telecommunications Products and Services; Value Added Products and Services; Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Big Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.